Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: Clues for clonal progression in prostate carcinogenesis

Molecular Cancer Research

Volumn 4, Issue 1, 2006, Pages 1-8

  Henrique, Rui ^a,b,c   Jerónimo, Carmen ^a,b,d   Teixeira, Manuel R ^b,c   Hoque, Mohammad O ^a   Carvalho, André L ^a   Pais, Irene ^b   Ribeiro, Franclim R ^b   Oliveira, Jorge ^b   Lopes, Carlos ^c   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; EPIGENETICS; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; MALE; METHYLATION; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS;

AGED; ALLELES; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; CLUSTER ANALYSIS; DISEASE PROGRESSION; EPIGENESIS, GENETIC; HUMANS; MALE; METHYLATION; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 32944480348     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-05-0113     Document Type: Article

References (42)

1. Jemal A, Tiwari RC, Murray T, et al. American Cancer Society. Cancer statistics 2004. CA Cancer J Clin 2004;54:8-29.
2. Montironi R, Mazzucchelli R, Scarpelli M. Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. Ann N Y Acad Sci 2002;963:169-84.
3. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-85.
4. Bostwick DG, Montironi R, Sesterhenn IA. Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report. Scand J Urol Nephrol Suppl 2000;205:3-10.
5. Montironi R, Mazzucchelli R, Stramazzotti D, Pomante R, Thompson D, Bartels PH. Expression of π-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma. Mol Pathol 2000;53:122-8.
6. Emmert-Buck MR, Vocke CD, Pozzatti RO, et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995;55:2959-62.
7. Qian J, Bostwick DG, Takahashi S, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55:5408-14.
8. Haggman MJ, Wojno KJ, Pearsall CP, Macoska JA. Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma. Urology 1997;50:643-7.
9. Bostwick DG, Shan A, Qian J, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer 1998;83:1995-2002.
10. Ruijter ET, Miller GJ, van de Kaa CA, et al. Molecular analysis of multifocal prostate cancer lesions. J Pathol 1999;188:271-7.
11. Beheshti B, Vukovic B, Marrano P, Squire JA, Park PC. Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci. Cancer Genet Cytogenet 2002;137:15-22.
12. Bastacky S, Cieply K, Sherer C, Dhir R, Epstein JI. Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy. Hum Pathol 2004;35:281-9.
13. Ashida S, Nakagawa H, Katagiri T, et al. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res 2004;64:5963-72.
14. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54.
15. Jerónimo C, Usadel H, Henrique R, et al. Quantitation of GSTP1 hypermethylation distinguishes between non-neoplastic prostatic tissue and organ confined prostate adenocarcinoma. J Natl Cancer Inst 2001;93:1747-52.
16. Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2002;8:514-9.
17. Yamanaka M, Watanabe M, Yamada Y, et al. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 2003;106:382-7.
18. Kang GH, Lee S, Lee HJ, Hwang KS. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol 2004;202:233-40.
19. Jerónimo C, Henrique R, Hoque MO, et al. Quantitative RARβ2 hypermethylation: a promising prostate cancer marker. Clin Cancer Res 2004;10:4010-4.
20. Jeronimo C, Henrique R, Hoque MO, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 2004;10:8472-8.
21. Henrique R, Jeronimo C. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol 2004;46:660-9.
22. Woodson K, Gillespie J, Hanson J, et al. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate 2004;60:25-31.
23. Jerónimo C, Varzim G, Henrique R, et al. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2002;11:445-50.
24. Nakayama M, Bennett CJ, Hicks J, et al. Hypermethylation of the human glutathione S-transferase π gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate. Am J Pathol 2003;163:923-33.
25. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998;58:4515-8.
26. Jerónimo C, Usadel H, Henrique R, et al. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 2002;60:1131-5.
27. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
28. Clark SJ. Studying mammalian DNA methylation: bisulfite modification. In: Esteller M, editor. DNA methylation. Approaches, methods and applications. Boca Raton: CRC Press; 2004. p. 60.
29. Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer 1985;56:1566-73.
30. Epstein JI. Prostatic intraepithelial neoplasia. In: Epstein JI, editor. Prostate biopsy interpretation. Philadelphia: Lippincott-Raven; 1995. p. 45.
31. Waki T, Tamura G, Sato M, Motoyama T. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 2003;22:4128-33.
32. Troncoso P, Babaian RJ, Ro JY, Grignon DJ, von Eschenbach AC, Ayala AG. Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology 1989;34:52-6.
33. Harden SV, Sanderson H, Goodman SN, et al. Quantitative GSTP1 methylation improves the detection of prostate adenocarcinoma in sextant biopsies. J Natl Cancer Inst 2003;95:1634-7.
34. Nelson WJ, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366-81.
35. Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C. Prostate. In: Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C, editors. Illustrated guide to the TNM/pTNM classification of malignant tumors. Heidelberg (Germany): Springer-Verlag; 1997. p. 278-80.
36. Gleason DF, Mellinger GT: Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol 1974;111:58-64.
37. Drago JR, Mostofi FK, Lee F. Introductory remarks and workshop summary. Urology 1992;39:2-8.
38. Epstein JI, Grignon DJ, Humphrey PA, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995;19:873-86.
39. Olek A, Oswald J, Walter JA. A modified and improved method of bisulfite based cytosine methylation analysis. Nucleic Acids Res 1996;24:5064-6.
40. Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-5.
41. Harden SV, Guo Z, Epstein JI, Sidransky D. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 2003;169:1138-42.
42. Henrique R, Jerónimo C, Hoque MO, et al. Frequent 14-3-3σ promoter methylation in benign and malignant prostate lesions. DNA Cell Biol 2005;24:264-9.